<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 42 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page41.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=42">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 42 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 42</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=42"><img src="../thumb/42.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>Central Nervous System - 1.4.2 / 1.4.3 / 1.4.3.1 / 1.4.3.2 / 1.4.4              2020-04 / 11
                                     Contraindications: Safety & effic.in childr./ adolesc. und.18 yrs.  mostly ecchymos.& purpura, hyperprolactinaem./galactorrh., sero-
       1.4.2  Non-Tricyclic          not est., MAOI’s.            ton.syndr., mydrias.
                                                                  Special precautions: Combin.with cognit. behav. ther.for panic
                                     Side effects: Cutan.bleed.abnormal., withdr. sympt. if abrupt dis-
              No products listed     cont., angioed., thrombocytopen., anaphylact./skin reacts., inappropr.   disord., mania hist., concom. neurolept./anticoags., elderly, sev.
                                     ADH secret., appet./weight chang., hyponatraem., psych.disords.incl.  ren./ hepat. impairm., concom.alcoh.not advis., discont.if liv. funct.
       1.4.3   Mono-Amine Oxidase    suic.ideat., bruxism, CNS effs., dizzin., trem., somnol., seroton. syndr.,   abnormalit./seiz.occur, concom. Li ther., admin.in ser.CV disords.
                                                                  not studied., epilep., little clinic.exper.with ECT, narrow angle glauc
                                     headache, convuls., drowsin., movem./ ejaculat. disord., abnorm.vis.,
              inhibitors             mydrias., orthostat. hypotens., yawn., sinusit., GI disturbs.incl. bleed./   Drug interactions: Poss.incr.bleed.in pres.of unalter. prothrob. times
                                     taste disturbs., hepatit., incr.sweat., ecchymos., alopec., photosens.,
                                                                  with warfar., drug metabol. inhibit.poss.incr.bioavail.(e.g. cimetidine),
              No products listed     arthralg., myalg., urin.retent., decr. libido, impot., abnorm.femal.or-  drug metabol.induc..poss.decr.plasma conc. (e.g. phenytoin), hepat.
                                                                  cytochrome P450 isozyme CYP2D6 respons.for metabol.of debriso-
                                     gasm, galactorrh., hyperprolactinaem., metrorrhag., menorrhag.,
                                     fatig, pyrex., abnorm.LFT.   quine & sparteine enhanc.plasma lev.of concom.meds. metabol.
       1.4.3.1  Non-selective mono-  Warnings and special precautions: Discont.if manic phase en-  by this isoenzyme., poss. seroton.syndr. with tryptophan, incr.pro-
                                     ter./seiz.devel./incr.seiz.freq./ seroton. syndr.devel., mania/hypoman.
                                                                  cyclidine plasma lev.& other anti-cholinergs, incr.incid.of adverse
              amine oxidase inhibitors  hist., low. start. dos.in panic disord.pts., epilep., diab.mellit., bleed.   effs. with anti-convuls.
                                     disord.hist., concom.meds.known alter. platel. funct., concom.ECT,
                                     caref.monit.for poss. suic., other psych./non-psych.disords., monit.  ADCO-TALOMIL, AI Pharm Ltd [P/S]
       PARNATE, Litha [P/S]          pts. esp. dur.early ther.& dos.chang.for clinic.worsen./ suicid. ideat./  Citalopram hydrobromide.equiv.to citalopram
       Tranylcypromine.              behav., consid.chang.therap.regim./ discont. if psych.sympts. occur   Indications: Depress., prevent.of relapse, obsess.compuls.disord.,
       Indications: Depress.         which are sev./ abrupt in onset/not part of pres.sympts., taper dos.   panic disord.with/without agoraphob.
       (S5) TABS. B1034.             dur. discont., poss.seroton.syndr.with concom. meds with seroton-  (S5) TABS, 35/1.2/0272
       752975-103: 10 mg, 28, R102,70  erg.effs., concom.cimetidine/ selegiline, monit.INR with concom.  702769-001: 20 mg, 30, R78,84
       Dosage: Init. 1 tab.morn.& aftern.incr.if necess. aft. 2 wks.to 1 tab.   oral anticoags., concom. meds.poss.low.seiz.thresh., safety in pregn.   Dosage: Depression: Treatm.period 6 mnths.to minimise relapse
       3xdly. Reduc.to maint.level when satisfact.respon.is obt.  & lactat.not est., poss.excret.in breast milk, elderly &gt;65 yrs., no info   potent. Adults: 20-60 mg as sngl. dly.dos. Elderly: 20 mg dly.incr.to
       Contraindications: Cerebrovasc./CV-dis., liv. damage, bld.dyscras.,   avail.in sev.ren. funct. impairm., hepat.insuff., discont.sympt.may   max.30 mg dly depend. on indiv.respons.
       hypertens., phaecromocyt., other MAOIs, dibenzazepine derivat., sym-  cont.for 2-3 mnths. or long.  OCD: 20 mg dly as sngl.dos. Can be incr.with 20 mg incr.to max.60
       pathomimet., foods high in tyramine.  Interactions: Cimetidine incr.AUC & C max., poss. seroton.syndr.with   mg/day depend.on respons.
       Side effects: Insomn., dizz., palpits., weakn., dry mouth, drowsin.,   MAOI, enhanc.seroton. assoc. effs. with other serotonerg.meds.&   Panic disord: Init.10 mg dly.incr.to 20 mg dly.aft. 1 wk., dos.may be
       postur.hypotens., incr.anx.& agitat., manic sympt., hypertens.crisis.  antidepress. with serotonerg.propert., enhanc. effs.with Li & tryp-  incr.further to max.60 mg dly.as reqd.
       Special precautions: Diabet., epilept., surg. (discont. at least 14   tophan, selegiline AUC incr., imipramine & desipramine plasma lev.  Contraindications: Sev.imp.ren.funct., safety in pregn. & lactat.not
       days bef.), pregn., lactat.   incr., metoprolol incr.AUC & C max., incr. prothromb.time aft.warfar.  est., MAOI, safety & effic.not est.in childr.und.18 yrs.
       Drug interactions: Guanethidine (act.antagon.), reserpine (poss.   Side effects: Sweat., CNS effs., GI disturbs., palpitat., decr.pulse
       hyperactiv.) alpha-methyldopa (poss. centr. excitat.), other hypoten-  ACTI-LIFT, (Activo) Glenmark [P/S]  rate, accommodat.disturbs., micturit.disords., fatig./asthen., weight
       siv.(poss. addit. eff.), barbits.(act.prolong./potentiat.), anti-parkinson.   Citalopram hydrobromide.  loss/ gain, sex.dysfunct., convuls., extrapyramid.effs., mydrias., nas.
       agents (poss.potentiat.).     Indications: Depress.& relapse prevent., panic disord. with/without   congest., salivat., rash, malaise, hyponatraem.
                                     agoraphob., obsess.compuls. disords.  Special precautions: Use of concom. electroconvuls. treatm.not
                                     (S5) TABS. 41/1.2/0297       est., discont.if pt.enters manic phase, reduc.hepat.funct., withdr.
       1.4.3.2  Selective mono-amine   717372-001: 20 mg, 30, R77,35  grad., monit.pts dur.early ther.as suicide inherent risk, epilep./such
                                     Dosage: Depression: Adults: 20 mg as sngl. dly.dos. May be incr.by
                                                                  disord.hist., alt.glycaem.control of diabet., thrombocytopen., platelet
              oxidase inhibitors     20 mg/day at interv. of at least one wk.to max.60 mg/day.  dysfunct., other concom. antidepress. ther.may result in sev.reacts.
                                                                  incl.”seroton. syndr.”, allow 1 wk.aft.withdr.of an SSRI and init.other
                                     Panic disord: 10 mg dly.1st. wk.then incr.to 20 mg dly., may furt.
                                     be incr.to max.60 mg dly.    meds.liable to provoke ser. react.
       DEPNIL, Cipla Medpro [P/S]    Obsess.compuls.disord: Init.20 mg as sngl.dos. which may incr.   Drug interactions: Interact.with imipramine, moclobemide, se-
       (300 mg: Hexal applic. Cipla Medpro market.)  by 20 mg increm.to max.dly.dos.of 60 mg.  legiline & sumatriptan, eliminat.of agents depend.on sparteine
       Moclobemide.                  Elderly: 20 mg/day as sngl.dos. which may be incr.to 30 mg/day.   oxygenase decr.
       Indications: Maj.depress., disabl.social phobia.  Dos.incr.depend. on pts.respons. Onset of action with. 2-4 wks. Ther.  AROPAX, GSK [P/S] &
       (S5) TABS, 35/1.2/0251, 36/1.2/0049  to be contin.for up to 6 mnths. aft.recov. mimim.relapse prevent.  Paroxetine
       897213-009: 150 mg, 60, R375,56  Contraindications: MAOIs, sev. imp.ren.funct., safety & effic.in   Indications: Sngl.episod.& recurr.depress.with assoc.anx.esp.where
       702008-001: 300 mg, 60, R480,57  pregn.& lactat.not est., childr.und.18 yrs.  sedat.not requir., low.dos. treatm.for up to 1 yr.to prev.relapse & re-
       Dosage: Admin.dly.in 2-3 div.dos.aft.food.  Side effects: Incr.seiz.risk, heart rate reduc., hypoglycaem., anx., hos-  curr.of furth. depress.episod., panic disord.with/without agorapho-
       Major depression: Dos.range: 300-600 mg dly.in div. dos. Init:   tilit., psych./resp./eye/ card./ micturit. disords., CNS eff., headache,   bia, short term treatm.of sev.disabl. obsess. compuls.disord., social
       300 mg dly which should not be exceed. dur.1st wk.as bioavail.incr.  dizzin., convuls., somnol., confus., malaise, seroton. syndr., NMS,
       dur.this period. Indiv. respons. may allow for reduct.to 150 mg dly.  akathis., anx., trem., fatig., weight chang., GI disturbs., salivat., sex.  phobia., generalis. anx.disord.
                                                                  (S5) TABS, Y/1.2/419,
       Social phobia: Recomm.dos: 600 mg/day in 2 div. dos. Day 1-3:   dysfunct. incl. decr.libido, hepatit., asthen., mydrias., nas. congest.,
       300 mg/day incr.to 600 mg/day on day 4. Contin.for 6-8 wks.to as-  sweat., skin reacts., yawn., suic.ideat.  791571-009: 20 mg, 28, R418,80
                                                                  Dosage: Admin.once dly.in the morn.with food. Swallow whole.
       sess effic. Long-term studies indic. effic.is maintain. with cont.use.   Special precautions: Elderly, ren./hepat. impairm., seiz./hist.
       but pt.should be re-eval.periodic.  thereof, epilep., ECT, man./ hist. thereof, discont.ther.if manic phase   Depress: Recom.dos: 20 mg dly. If necess.may be incr.grad.in 10 mg
       Contraindications: Ac.confus.states, safety in childr/pregn.& lactat.  enter., pre-exist. slow heart rate, diab.mellit., concom. imipramine/  increm.to max.50 mg/day accord. to pt.response.
       not est., concom.selegiline, schizophren., schizoaffect.organ.disords.,   other serotonerg.meds./ moclobemide/ alcoh./warfar./cimetidine   Panic disord: Recomm.dos: 40 mg dly. Init.10 mg /day incr.wkly
       concom. serotonin 5-HT re-uptake inhibits., concom. Pethidine not   C/I, seroton. syndr.risk, more likely aft.dos.incr., worsen. depress./  in 10 mg increm.accord.to respons. Max.60 mg/day. Low init.start.
       recomm., phaeochromocyt.      suic.thoughts & ideat., monit. pts.esp.dur.early ther.& dos.chang.for   dos.is recomm.
       Side effects: Sleep/GI/vis.disturbs., CNS effs., paraesthes., dry   clinic. worsen./suicidal., monit.other psych.& non-psych. disord.pts.,   OCD: Recomm.dos: 40 mg dly. Init.20 mg/day incr. weekly.in 10 mg
       mouth, skin reacts., hypotens., hypersens., sev.CNS effs.with dex-  consid.chang. therap.regim./discont. ther.if psych.sympt.occur which   increm.accord.to respons. Max. 60 mg/day.
       tromethorphan, poss. manic episod.in pts.with bipol.disords., hy-  are sev./abrupt in onset/ not part of pres.sympt., withdr.grad.by dos.   Social phobia: Recomm.dos: 20 mg dly. Incr. dos. in 10 mg increm.
       ponatraem. esp.in elderly pts., bld.dyscras.  taper., excret.in breast milk, reduc.hepat.funct., avoid alcoh., incr.hos-  as requir. Max.dly.dos: 40 mg accord. to response
       Special precautions: Hepat.impairm., monit.pts. with suicid. ten-  tilit./suic.-relat.adverse events/ self-harm in childr.  Gen.anx.disord: Recomm.dos. 20 mg dly. If unrespons. incr.dos.as
       den., tyramine-rich food in hypertens., thyrotoxicos., phaechromocy-  Drug interactions: Ser./potent.fatal reacts.with MAOIs, incr.  reqd.to max.50 mg/day
       toma, concom. meds.that enchanc.serotonin esp. clomipramine as   desipramine plasma conc., interacts. with moclobemide, incr.sero-  (S5) CR TABS, A38/1.2/0612, 0613
       serotonergic.overactiv.poss., wash-out period of 4-5 times half-life   ton.syndr.devel.risk with other serotonerg.meds./meds.with seroton-  Indications: Maj.depress.disord., panic disord. with/-out agora-
       aft.stop.5-HT re-uptake inhibit., concom.cough & cold meds.as they   erg. activ., incr.alcoh.eff., anticoag act.of warfar. incr., incr.AUC/max.  phob., soc.phob.
       may cont.dextromethorphan,, passes into breast milk, depress.pts.  plasma conc.incr.with cimetidine.  704647-002: 12,5 mg, 30, R278,32
       with excitat./agitat.to be treat. in combinat. with sedat.for not more   704646-002: 25 mg, 30, R344,23
       than 2-3 wks., poss.hypertens.react.in concom.centr.act. anti-hyper-  ADCO-PAROXETINE, AI Pharm [P/S]  Dosage: Admin.once dly.in the morn.with food. Swallow whole. Re-
       tens.& gangl.block.agents, grad.dos. reduct.  Paroxetine   view & adjust dos.if necess. within 2-3 wks.of init.ther.
       Drug interactions: Effs.of opioid analges. potent., cimetidine incr.  Indications: Sngl.episod.& recurr.depress.with assoc.anx.esp.  Maj.depress.disord: Init. 25 mg/day. Incr.at 1 wk. interv.in 12,5
       plasma conc., pharmacolog. eff.of syst.admin. sympathomimets.   where sedat.not requir., low.dos. treatm. for up to 1 yr.to prev.re-  mg increm.to max.62,5 mg/day if necess.accord.to respons. Treat.
       poss. potent.& prolong, hypertens.cris.with levodopa.  lapse & recurr.of furth. depress.episod., panic disord.with/without   for suffic.period to ensure pt.sympt.free which may be sev.mnths.
                                     agoraphobia, short term treatm.of sev.disabl. obsess. compuls.  Panic disord: Init.12,5 mg/day incr.wkly.in 12,5 mg/ day increm.ac-
                                     disord., social phobia.      cord.to pt.respons.. Max: 75 mg/day. Treat.for suffic.period to ensure
       1.4.4   Selective serotonin    (S5) TABS, 36/1.2/0096      pt. sympt. free which may be x sev.mnths.
                                                                  Soc.phob: Init.12,5 mg dly.incr.at 1 wk.interv.in 12,5 mg/day increm.
                                     704904-001: 20 mg, 30, R174,72
              re-uptake inhibitors   Dosage: Admin.once dly.in the morn.with food. Swallow whole.  accord.to pt.respons.upto max. 37,5 mg/day.
                                     Depress: Recom.init.dos.20 mg dly. If necess.may be incr.grad.in
                                                                  Contraindications: MAOI, safety & effic.in childr. und.18 yrs.not
       AROPAX (MDR Listing)          10 mg increm.to max.50 mg/day accord. to pt.response.  est., pregn., safety in lactat.not est., concom. thioridazine/pimozide,
                                                                  concon. seroton. precurs.(eg.L-tryptophan, oxitriptan) incr. serotonerg.
                                     Panic disord: Recomm.dos: 40 mg dly. Init. 10 mg /day incr.in
       CILIFT (MDR Listing)          10 mg wkly.increm.accord.to respons. Max.60 mg/day. Low init.  syndr.risk.. CR Tabs only: lact.intol.
       CIPRALEX (MDR Listing)        start.dos.is recomm.         Side effects: Abnorm.bleed.predomin.of skin & mucous membr.
       ZOLOFT (MDR Listing)          OCD: Recomm.dos: 40 mg dly. Init.20 mg/day incr. in 10 mg wkly.  (mostly ecchymos.also GI tract/ CNS & eye). allerg. reacts. SIADH,
       ACCORD ESCITALOPRAM, Accord [P/S]  increm.accord.to respons. Max. 60 mg/day.  decr appetite., hyponatraem.esp.in elderly, psych.disord., manic re-
       Escitalopram oxalate          Social phobia: Recomm.dos: 20 mg dly. Incr. dos. in 10 mg wkly.  acts., CNS effs., extrapyramid.sympts., convuls., seroton. syndr., blurr.
       Indications: Maj.depress.episod.  increm.as requir. Max.dly.dos: 40 mg accord.to response  vis., ac glauc., yawn., GI disords., dry mouth, elev.hepat.enzyme., hep-
       (S5) TABS, 44/1.2/0851, 0852  Contraindications: MAOI, safety & effic.in childr. not est., lactat.,   atit. poss. assoc.with jaund./liv.fail., sweat., skin rash, photosens.
       719547-001: 10 mg, 28, R56,01  safety in pregn.not est.    reacts., urin.retent., sex.dysfunct., hyperprolactinaem./ galactorrh.,
       719548-001: 20 mg, 28, R75,60  Side effects: GI disords., sex.dysfunct., CNS effs., sweat., trem.,   asthen., periph. oed., neurolept malign.syndr., akathis.
       Dosage: Adults: Maj.depress.episod: 10 mg as sngl.dly dos. May   asthen., dry mouth, elev. hepat. enzyme., extrapyramid. sympts.  Warnings and special precautions: Monit.pts. for clinic.worsen.&
       be incr.to max.20 mg dly. depend.on indiv.respons.2-4 wks.necess.  aggrav. Parkins. dis., hyponatraem.esp.in elderly, ac glauc., urin.   suicide.through.treatm.& esp. at begin.of treatm./dos.chang., worsen.
       for antidepress. respons.     retent., periph.& fac.oed., neurolept.malign.syndr., abnorm. bleed.  depress./ emerg. suicide ideat./-behav risk in maj.depress. /psych.</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page41.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page37.html">37</a>&nbsp;&nbsp;&nbsp;<a href="page38.html">38</a>&nbsp;&nbsp;&nbsp;<a href="page39.html">39</a>&nbsp;&nbsp;&nbsp;<a href="page40.html">40</a>&nbsp;&nbsp;&nbsp;<a href="page41.html">41</a>&nbsp;&nbsp;&nbsp;<a href="page42.html">42</a>&nbsp;&nbsp;&nbsp;<a href="page43.html">43</a>&nbsp;&nbsp;&nbsp;<a href="page44.html">44</a>&nbsp;&nbsp;&nbsp;<a href="page45.html">45</a>&nbsp;&nbsp;&nbsp;<a href="page46.html">46</a>&nbsp;&nbsp;&nbsp;<a href="page47.html">47</a>
             </td>
             <td width="35%"><a href="page43.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page43.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
